Pharma News
-
Chinese police probe GSK staff for 'economic crimes'
Pharma | News | By BioSpectrum Bureau | 0 Comment | 02 Jul, 2013
Singapore: The Chinese police have been investigating senior staff from the Chinese office of the British drug major Gl...Read more
-
Pharma | Company results | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
‎Singapore: ShangPharma, a leading China-based pharmaceutical and biotechnology research and development outsourci...Read more
-
Japanese I'rom acquires 18% in Australian IDT
Pharma | News | By BioSpectrum Bureau | 0 Comment | 07 May, 2013
Singapore: Japanese company I'rom Holdings will acquire an 18.8 percent stake in IDT Australia. I'rom is listed on the T...Read more
-
Indian drug approval mechanism under fire
Pharma | Analysis | By BioSpectrum Bureau | 0 Comment | 17 Aug, 2012
On May 8, when Mr Brajesh Pathak, chairman of India's parliamentary standing committee on health and family welfare, pre...Read more
-
Iressa deaths: Japanese High Court rules in favor of AZ
Pharma | News | By BioSpectrum Bureau | 0 Comment | 28 May, 2012
Singapore: The Japanese unit of AstraZeneca (AZ), has been acquitted, in a case that had held the firm responsible for t...Read more
-
Sinopharm bullish on expansion
Pharma | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2012
Sinopharm Group continued to dominate the pharmaceutical industry in China and across the Asia Pacific region ...Read more
-
Prima recruits patients for cancer vaccine trial
Pharma | News | By BioSpectrum Bureau | 0 Comment | 01 Mar, 2013
Singapore: Prima BioMed has commenced recruitment of patients into the Canvas (Cancer Vaccine Study) trial in Europe. P...Read more
-
Merck pays Bionomics $172mn for pain molecules
Pharma | News | By BioSpectrum Bureau | 0 Comment | 01 Aug, 2013
Singapore: Bionomics entered in an agreement with Merck, which is also known as Merck Sharp and Dohme outside the US and...Read more
-
Bayer initiates trial of new rFVIII to treat hemophilia A
Pharma | News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2012
Singapore: Bayer HealthCare started enrolling patients in an international phase II/III trial called PROTECT VIII that i...Read more
-
Alchemia demerges Audeo on NASDAQ, ASX
Pharma | News | By BioSpectrum Bureau | 0 Comment | 02 Jan, 2013
Singapore: Alchemia has demerged its subsidiary, Audeo Oncology, on NASDAQ and the ASX. The company has announced that i...Read more
-
Pfizer cancer drug gets first-ever China SFDA nod
Pharma | Regulatory | By BioSpectrum Bureau | 0 Comment | 25 Feb, 2013
Singapore: Pfizer received approval for Xalkori (crizotinib) for Chinese State Food and Drug Administration (SFDA), as t...Read more
-
Onyx rejects $10 bn takeover bid by Amgen
Pharma | News | By BioSpectrum Bureau | 0 Comment | 02 Jul, 2013
Singapore: Onyx Pharmaceuticals rejected a $10 billion takeover offer from Amgen as too low but still is considering sel...Read more
-
CSIR head: Indian bioscience education disappoints me
Pharma | Opinion | By BioSpectrum Bureau | 0 Comment | 13 May, 2013
In 2002, biotechnology was just in its nascent stage and was considered to be a small industry. However, the success sto...Read more
-
Daiichi Sankyo, Ranbaxy to leverage synergies in Thailand
Pharma | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Japan's Daiichi Sankyo and Ranbaxy Laboratories have plans to integrate their business operations in Thailand...Read more
-
ScinoPharm, Coland develop cancer generics in China
Pharma | News | By BioSpectrum Bureau | 0 Comment | 13 May, 2013
‎Singapore: ScinoPharm Taiwan and Taiwan-listed, China-based company, Coland, have formed a strategic alliance to ...Read more
-
Hoya appoints new executive officer
Pharma | News | By BioSpectrum Bureau | 0 Comment | 26 May, 2014
Singapore: Japan based Hoya Corporation has appointed Mr Augustine Yee as its executive officer, chief legal officer and...Read more
-
Ninad Deshpanday is Kemwell R&D president
Pharma | News | By BioSpectrum Bureau | 0 Comment | 15 Feb, 2013
Bangalore: India-based Kemwell Biopharma appointed Dr Ninad Deshpanday as president of R&D. Dr Deshpanday has over 2...Read more
-
China's Fosun strikes $534 mn deal with Swiss Sellas
Pharma | News | By BioSpectrum Bureau | 0 Comment | 25 Oct, 2013
Singapore: In what could be a landmark deal, China's largest biotech company has struck a deal worth $534 million with S...Read more
